Osamu Gotoh

Japanese Foundation For Cancer Research — Japan

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

53h-index13.9kcitations167works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(24), RNA and protein synthesis mechanisms(14), Traumatic Brain Injury and Neurovascular Disturbances(11), DNA and Nucleic Acid Chemistry(10), DNA Repair Mechanisms(9)

Publications167 total

Genomic and DNA methylomic factors associated with the efficacy of oral medroxyprogesterone acetate on endometrial neoplastic disease
Gynecologic Oncology·2025
Abstract 6606: Genomic features of histological and molecular subtypes in Japanese ovarian cancer
Cancer Research·2025
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Breast Cancer·2024· 1 citedOpen Access
Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma
The Journal of Pathology·2024· 16 citedOpen Access
Clinical landscape of TP73 structural variants in ATL patients
Leukemia·2023Open Access
Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer
JAMA Network Open·2023· 14 citedOpen Access
Genomic features of <i>Helicobacter pylori</i>‐naïve diffuse‐type gastric cancer
The Journal of Pathology·2022· 11 citedOpen Access
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
Journal for ImmunoTherapy of Cancer·2022· 4 citedOpen Access
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
Haematologica·2022· 19 citedOpen Access
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
2021· 2 citedOpen Access
A method of sample-wise region-set enrichment analysis for DNA methylomics
Epigenomics·2021· 6 cited
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms
Journal of Human Genetics·2021· 10 cited
Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample
Cancer Science·2021· 7 citedOpen Access
Immunogenomic landscape of gynecologic carcinosarcoma
Gynecologic Oncology·2020· 12 cited
Immunogenic characteristics of microsatellite instability‐low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses
International Journal of Cancer·2020· 11 citedOpen Access
T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer
Cancer Immunology Immunotherapy·2020· 42 citedOpen Access
Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
npj Breast Cancer·2020· 40 citedOpen Access
Sequencing artifacts derived from a library preparation method using enzymatic fragmentation
PLoS ONE·2020· 51 citedOpen Access
Datasets and metadata supporting the published article: Prevalence of Disease-Causing Genes in Japanese Patients with BRCA1/2-Wildtype Hereditary Breast and Ovarian Cancer Syndrome
Figshare·2020· 1 citedOpen Access
Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma
American Journal Of Pathology·2019· 31 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Kazuhiro Sogawa(11), Yusaku Tagashira(10), Kaname Kawajiri(8), Hiromichi Yonekawa(7), Y Fujii-Kuriyama(6), Nobumoto Miyashita(5), Yoshiaki Fujii‐Kuriyama(4), Junko Watanabe(4), M. Noshiro(4), Masatsugu Ema(3), Kintomo Takakura(3), Kazuo Moriwaki(3), Akira Tamura(3), Keiji Sano(3), Jun‐Ichi Hayashi(3), Yuzo Yoshida(3), Noboru Yokotani(3), Emi Kusunose(3), David R. Nelson(2), René Feyereisen(2)